BRD9 and cancer: Overexpression of BRD9 has been observed in various cancers, including non-small-cell lung cancer, hepatocellular carcinoma, pediatric rhabdoid tumors, prostate cancer, and cervical cancer, making it a compelling target for the development of a new therapy for the treatment of a number of human cancers [80,81].